JP2007529714A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529714A5
JP2007529714A5 JP2007502088A JP2007502088A JP2007529714A5 JP 2007529714 A5 JP2007529714 A5 JP 2007529714A5 JP 2007502088 A JP2007502088 A JP 2007502088A JP 2007502088 A JP2007502088 A JP 2007502088A JP 2007529714 A5 JP2007529714 A5 JP 2007529714A5
Authority
JP
Japan
Prior art keywords
score
group
individual
allele
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007502088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007529714A (ja
Filing date
Publication date
Priority claimed from US10/956,224 external-priority patent/US7127355B2/en
Application filed filed Critical
Publication of JP2007529714A publication Critical patent/JP2007529714A/ja
Publication of JP2007529714A5 publication Critical patent/JP2007529714A5/ja
Withdrawn legal-status Critical Current

Links

JP2007502088A 2004-03-05 2005-03-03 遺伝子分析のための方法 Withdrawn JP2007529714A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55066204P 2004-03-05 2004-03-05
US56630204P 2004-04-28 2004-04-28
US59053404P 2004-07-22 2004-07-22
US10/956,224 US7127355B2 (en) 2004-03-05 2004-09-30 Methods for genetic analysis
PCT/US2005/007375 WO2005086770A2 (en) 2004-03-05 2005-03-03 Methods for genetic analysis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013151528A Division JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法

Publications (2)

Publication Number Publication Date
JP2007529714A JP2007529714A (ja) 2007-10-25
JP2007529714A5 true JP2007529714A5 (https=) 2008-04-17

Family

ID=34916521

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007502088A Withdrawn JP2007529714A (ja) 2004-03-05 2005-03-03 遺伝子分析のための方法
JP2013151528A Pending JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法
JP2016016966A Pending JP2016082984A (ja) 2004-03-05 2016-02-01 遺伝子分析のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013151528A Pending JP2013240344A (ja) 2004-03-05 2013-07-22 遺伝子分析のための方法
JP2016016966A Pending JP2016082984A (ja) 2004-03-05 2016-02-01 遺伝子分析のための方法

Country Status (4)

Country Link
US (2) US7127355B2 (https=)
EP (1) EP1725967A4 (https=)
JP (3) JP2007529714A (https=)
WO (1) WO2005086770A2 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis
US20090087854A1 (en) * 2007-09-27 2009-04-02 Perlegen Sciences, Inc. Methods for genetic analysis
US20060166224A1 (en) * 2005-01-24 2006-07-27 Norviel Vernon A Associations using genotypes and phenotypes
WO2006110853A2 (en) * 2005-04-12 2006-10-19 Maren Alianna J System and method for evidence accumulation and hypothesis generation
EP2468901B1 (en) 2005-11-29 2017-04-05 Cambridge Enterprise Limited Markers for breast cancer
US20110143344A1 (en) * 2006-03-01 2011-06-16 The Washington University Genetic polymorphisms and substance dependence
KR20080114773A (ko) * 2006-03-01 2008-12-31 펄리건 사이언시스, 인코퍼레이티드 중독에 대한 마커
CA2672246A1 (en) 2006-06-30 2008-03-13 Rosetta Genomics Ltd Detecting nucleic acids
US8005627B2 (en) * 2006-09-08 2011-08-23 Richard Porwancher Bioinformatic approach to disease diagnosis
GB2444410B (en) * 2006-11-30 2011-08-24 Navigenics Inc Genetic analysis systems and methods
US20080131887A1 (en) * 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
US20080228700A1 (en) * 2007-03-16 2008-09-18 Expanse Networks, Inc. Attribute Combination Discovery
US20090012839A1 (en) * 2007-07-03 2009-01-08 American Express Travel Related Services Company, Inc. Determining Brand Affiliations
US20090043752A1 (en) * 2007-08-08 2009-02-12 Expanse Networks, Inc. Predicting Side Effect Attributes
CN101842496A (zh) * 2007-09-26 2010-09-22 纳维哲尼克斯公司 使用祖先数据进行基因组分析的方法和系统
WO2009085196A1 (en) * 2007-12-21 2009-07-09 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
US20090326832A1 (en) * 2008-06-27 2009-12-31 Microsoft Corporation Graphical models for the analysis of genome-wide associations
KR20110053995A (ko) * 2008-08-08 2011-05-24 네이비제닉스 인크. 개인별 활동 계획을 위한 방법 및 체계
US8200509B2 (en) 2008-09-10 2012-06-12 Expanse Networks, Inc. Masked data record access
US7917438B2 (en) * 2008-09-10 2011-03-29 Expanse Networks, Inc. System for secure mobile healthcare selection
GB2477868A (en) * 2008-09-12 2011-08-17 Navigenics Inc Methods and systems for incorporating multiple environmental and genetic risk factors
US8386519B2 (en) 2008-12-30 2013-02-26 Expanse Networks, Inc. Pangenetic web item recommendation system
US20100169338A1 (en) * 2008-12-30 2010-07-01 Expanse Networks, Inc. Pangenetic Web Search System
US8255403B2 (en) 2008-12-30 2012-08-28 Expanse Networks, Inc. Pangenetic web satisfaction prediction system
US8108406B2 (en) * 2008-12-30 2012-01-31 Expanse Networks, Inc. Pangenetic web user behavior prediction system
WO2010077336A1 (en) 2008-12-31 2010-07-08 23Andme, Inc. Finding relatives in a database
US20120323600A1 (en) * 2009-05-07 2012-12-20 Pathway Genomics Genome-based drug management systems
DK2438193T3 (en) 2009-06-01 2015-10-19 Genetic Technologies Ltd Methods for assessing the risk of breast cancer
NZ598534A (en) * 2009-09-29 2014-03-28 Novartis Ag Dosage regimen of an s1p receptor modulator
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
BR112013010769A2 (pt) * 2010-11-01 2019-09-24 Genentech Inc predição de progressão para degeneração macular relacionada à idade avançada usando um escore poligênico
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
US20130218581A1 (en) * 2011-04-26 2013-08-22 Selventa, Inc. Stratifying patient populations through characterization of disease-driving signaling
US20140378351A1 (en) * 2013-06-22 2014-12-25 Brian Meshkin System and method for processing genotype information relating to treatment with pain medication
SG11201601044XA (en) 2013-08-12 2016-03-30 Genentech Inc Compositions and method for treating complement-associated conditions
AU2015253042A1 (en) 2014-05-01 2016-10-20 Genentech, Inc. Anti-factor D antibody variants and uses thereof
WO2016044233A1 (en) * 2014-09-18 2016-03-24 Illumina, Inc. Methods and systems for analyzing nucleic acid sequencing data
CA2962691C (en) 2014-09-30 2023-05-23 Genetic Technologies Limited Methods for assessing risk of developing breast cancer
EP3207161A4 (en) * 2014-10-14 2018-09-12 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with cancer risk
US10152298B1 (en) * 2015-06-29 2018-12-11 Amazon Technologies, Inc. Confidence estimation based on frequency
US10407510B2 (en) 2015-10-30 2019-09-10 Genentech, Inc. Anti-factor D antibodies and conjugates
EP3368090A1 (en) 2015-10-30 2018-09-05 H. Hoffnabb-La Roche Ag Anti-factor d antibody variant conjugates and uses thereof
JP7126704B2 (ja) 2016-01-28 2022-08-29 ザ ユニバーシティー オブ メルボルン 結腸直腸癌発症のリスクを評価するための方法
US20170240965A1 (en) * 2016-02-22 2017-08-24 Cedars-Sinai Medical Center Methods for prognosing heart transplant
US10783997B2 (en) 2016-08-26 2020-09-22 International Business Machines Corporation Personalized tolerance prediction of adverse drug events
RU2678441C1 (ru) * 2018-07-02 2019-01-29 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития гипертонической болезни с учетом генетических и средовых факторов
KR20230019872A (ko) 2020-05-27 2023-02-09 지네틱 테크놀로지스 리미티드 코로나바이러스 감염에 대한 중증 반응의 발생 위험을 평가하는 방법
EP4211150A4 (en) * 2020-09-10 2024-10-16 Microgenesis Corporation METHODS AND COMPOSITIONS FOR THE EVALUATION OF INFLAMMATORY DISEASES RELATED TO FERTILITY
US20230359707A1 (en) * 2020-10-14 2023-11-09 Craif Inc. Method for evaluating likelihood of observation value and program
US20250149176A1 (en) * 2023-11-08 2025-05-08 Optum Services (Ireland) Limited Model-based risk prediction and treatment pathway prioritization

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023A (en) * 1843-03-30 peters
US20020048749A1 (en) 1998-04-15 2002-04-25 Robert J. Lipshutz Methods for polymorphism identifcation and profiling
US5834248A (en) 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
US6274332B1 (en) 1995-12-22 2001-08-14 Univ. Of Utah Research Foundation Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
US5817461A (en) 1996-01-03 1998-10-06 Hamilton Civic Hospitals Research Development Inc. Methods and compositions for diagnosis of hyperhomocysteinemia
WO2000028080A2 (en) 1998-11-10 2000-05-18 Genset Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
US20040171056A1 (en) 1999-02-22 2004-09-02 Variagenics, Inc., A Delaware Corporation Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
AU5638600A (en) 1999-06-25 2001-01-31 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
US20020077756A1 (en) * 1999-11-29 2002-06-20 Scott Arouh Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
EP1248832A4 (en) * 2000-01-21 2004-07-07 Variagenics Inc IDENTIFICATION OF THE GENETIC COMPONENTS OF A MEDICINE REACTION
US6931326B1 (en) * 2000-06-26 2005-08-16 Genaissance Pharmaceuticals, Inc. Methods for obtaining and using haplotype data
WO2002016643A2 (en) * 2000-08-18 2002-02-28 Curagen Corporation Dna pooling methods for quantitative traits using unrelated populations or sib pairs
US20020098498A1 (en) 2000-09-29 2002-07-25 Bader Joel S. Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents
US6828103B2 (en) 2001-02-22 2004-12-07 Wake Forest University Genetic polymorphisms of estrogen receptor alpha associated with favorable response to hormone replacement therapy
AU2002322775A1 (en) * 2001-07-27 2003-02-17 The Regents Of The University Of California Stk15 (stk6) gene polymorphism and methods of determining cancer risk
US20040086886A1 (en) 2001-09-11 2004-05-06 Goldstein Steven A.N. Polymorphisms associated with cardiac arrythmia
US20030162207A1 (en) * 2001-12-14 2003-08-28 Comings David E. Multi-gene tests with ROC plots for the assessment of risk for polygenic disorders
AU2003212806A1 (en) * 2002-01-15 2003-07-30 Vanderbilt University Method and apparatus for multifactor dimensionality reduction
US20030232398A1 (en) * 2002-03-28 2003-12-18 Macmurray James P. Use of ROC plots of genetic risk factor to predict risk of sporadic breast cancer
US20040115701A1 (en) 2002-08-30 2004-06-17 Comings David E Method for risk assessment for polygenic disorders
WO2004044163A2 (en) * 2002-11-06 2004-05-27 Sequenom, Inc. Methods for identifying risk of melanoma and treatments thereof
US20050032066A1 (en) * 2003-08-04 2005-02-10 Heng Chew Kiat Method for assessing risk of diseases with multiple contributing factors
US20050037366A1 (en) * 2003-08-14 2005-02-17 Joseph Gut Individual drug safety
US7470513B2 (en) * 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions
US7127355B2 (en) * 2004-03-05 2006-10-24 Perlegen Sciences, Inc. Methods for genetic analysis

Similar Documents

Publication Publication Date Title
JP2007529714A5 (https=)
Zhou et al. Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
Hubner et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease
Voight et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits
Stranger et al. Patterns of cis regulatory variation in diverse human populations
US20200027557A1 (en) Multimodal modeling systems and methods for predicting and managing dementia risk for individuals
Guo et al. Exome sequencing generates high quality data in non-target regions
Zhang et al. SNPdetector: a software tool for sensitive and accurate SNP detection
Ebbert et al. Population-based analysis of Alzheimer’s disease risk alleles implicates genetic interactions
Yang et al. Comparison of genome sequencing and clinical genotyping for pharmacogenes
Schadt et al. A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets
Shahwan et al. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population
Daya et al. Using multi-way admixture mapping to elucidate TB susceptibility in the South African Coloured population
WO2004049234A1 (ja) 疾患感受性遺伝子の同定方法
KR102303638B1 (ko) 알츠하이머성 치매가 발병될 가능성 평가방법
US20220367063A1 (en) Polygenic risk score for in vitro fertilization
Pat et al. Motivation and cognitive abilities as mediators between polygenic scores and psychopathology in children
Simonin-Wilmer et al. An overview of strategies for detecting genotype-phenotype associations across ancestrally diverse populations
Jeff et al. Admixture mapping and subsequent fine-mapping suggests a biologically relevant and novel association on chromosome 11 for type 2 diabetes in African Americans
Guelly et al. Patients with coronary heart disease, dilated cardiomyopathy and idiopathic ventricular tachycardia share overlapping patterns of pathogenic variation in cardiac risk genes
Weisburd et al. Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing data sets
Yu et al. Detecting natural selection by empirical comparison to random regions of the genome
JP2019524115A (ja) 気分障害検査用バイオマーカーとしてのｒｎａ編集
Im et al. A population-specific low-frequency variant of SLC22A12 (p. W258*) explains nearby genome-wide association signals for serum uric acid concentrations among Koreans
CN102947466B (zh) 肌醇聚磷酸盐-4-磷酸酶-类型2-基因(INPP4b-基因)中的人类染色体4的单核苷酸多形性用于多发硬化症的诊断或者预诊断